Japan working on "drug lags" but still some way to go
This article was originally published in Scrip
Executive Summary
Japan has made progress towards one of its main pharmaceutical regulatory goals, that of reducing "drug lag", but will need to keep up the pace of change if it is to meet its official target for faster approvals.